The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Seagen Inc(NASDAQ:SGEN) 
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company markets ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADC...
Website: http://www.seattlegenetics.com
Founded: 1997
Full Time Employees: 1,605
Sector: Healthcare
Industry: Biotechnology
Seagen Days Payable Outstanding ttm (DPO)
Seagen Days Receivable Outstanding ttm (DSO)
Seagen Days Inventory Outstanding ttm (DIO)
Seagen Op Cashflow Per Share ttm
Seagen Free Cashflow Per Share ttm
Seagen Cash Per Share ttm
Seagen P/S ratio ttm
Seagen (GAAP) P/E ratio ttm
Seagen P/B ratio ttm
No extra charts and metrics for this ticker.